World's Best Scientists 2026 revealed!
Pharmacology Research and Perspectives
H-index 19

Pharmacology Research and Perspectives

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Neuroscience 360 26 22 6
Medicine 1774 103 83 14

Additional Metrics

Number of Best Scientists*: 238
Documents by Best Scientists*: 186
Top 100 Ranked Scientists*: 8
SCIMAGO H-index: 47
SCIMAGO SJR: 0.799
Impact Factor: 2.3

Overview

Top Research Topics at Pharmacology Research & Perspectives?

Pharmacology Research & Perspectives tackles a plethora of topics, such as Pharmacology, Internal medicine, Pharmacokinetics, Endocrinology and Receptor. The concepts on Pharmacology presented in it can also apply to other research fields, including Agonist, Antagonist and Metabolite. The research on Internal medicine tackled can also make contributions to studies in the areas of Gastroenterology and Cardiology.

The studies on Pharmacokinetics discussed can also contribute to research in the domains of Tolerability, Adverse effect and Dosing. It explores research in Receptor and the adjacent study of Cell biology.

  • Pharmacology (39.14%)
  • Internal medicine (26.91%)
  • Pharmacokinetics (15.80%)

What are the most cited papers published in the journal?

  • Analysis of drug combinations: current methodological landscape (508 citations)
  • Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. (211 citations)
  • Role of endoplasmic reticulum stress in drug‐induced toxicity (116 citations)

Research areas of the most cited articles at Pharmacology Research & Perspectives:

The aim of the journal papers is to expand the discussion of research in Pharmacology, Endocrinology, Internal medicine, Pharmacokinetics and Drug. Adverse effect is a primary topic of Pharmacology research in the journal papers. The published articles hold forums on Endocrinology that merge themes from other disciplines such as Fibrosis and Pathology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Enzyme

The previous edition focused in particular on these issues:

Pharmacology, Internal medicine, Pharmacokinetics, Adverse effect and Apoptosis are among the topics commonly tackled in the journal. The studies in Pharmacology featured incorporate elements of Cardioprotection, Transporter, Crossover study, Efflux and p38 mitogen-activated protein kinases. In addition to Internal medicine research, Pharmacology Research & Perspectives aims to explore topics under Gastroenterology, Endocrinology, Oncology and Cardiology.

The journal facilitates discussions on Pharmacokinetics that incorporate concepts from other fields like Tolerability, Antagonist and Dosing. While it focused on Adverse effect, it was also able to explore topics like Clinical trial and Drug. The featured Apoptosis studies mainly concentrate on Cancer research but also cover areas of interest in Downregulation and upregulation.

The most cited articles from the last journal are:

  • Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent (7 citations)
  • Drug-drug interactions with candidate medications used for COVID-19 treatment: An overview. (6 citations)
  • Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS-CoV-2 in the respiratory tract. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Pharmacology Research & Perspectives (based on the number of publications) are:

  • Jennifer H. Martin (5 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Ryoichi Fujiwara (5 papers) absent at the last edition,
  • Jacobus Burggraaf (5 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Andrew J Lawrence (5 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Olufunsho Awodele (4 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Pharmacology Research & Perspectives (based on the number of publications) are:

  • AstraZeneca (17 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Janssen Pharmaceutica (14 papers) published 2 papers at the last edition the same number as at the previous edition,
  • GlaxoSmithKline (14 papers) absent at the last edition,
  • University of Copenhagen (14 papers) published 1 paper at the last edition,
  • University of Nottingham (10 papers) published 3 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.18% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 7.74% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.31% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.48% of all publications and 65.48% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Requirements in Pharmacology Field

It is crucial for individuals interested in pursuing a career in pharmacology to understand the educational requirements and potential career paths in this field. Jobs in pharmacology differ based on their areas of specialization, which include Clinical Pharmacology, Pharmacokinetics, and many others. Each of these specializations has unique job roles, descriptions, and requirements.

To illustrate, Clinical Pharmacologists are involved in the evaluation of drugs, their usage, and their effects on the human body. They often work in clinical settings, interacting directly with patients, under the supervision of Medical Doctors and are required to have a thorough understanding of drug usage and dosage, adverse effects, and contraindications. On the other hand, experts in Pharmacokinetics often work in research labs; they focus on understanding how the body processes drugs, including absorption, distribution, metabolism, and excretion.

The roles available in this field require specific educational qualifications with a good foundation in biology, chemistry, medical sciences, calculus, and statistics. As such, the common academic journey begins with a Bachelor's degree in Biology, Chemistry, or a related field, followed by a Master’s or Doctorate degree in Pharmacology. Some roles may also require licensing or certification. This field also requires continuous learning to keep up with the latest advancements, like new drugs and treatment methods.

It's important to note that the specific requirements and career paths in pharmacology also may vary based on location. If you’re interested in becoming a pharmacologist in a specific state, it would be helpful to research the specific requirements in that state. For instance, if you wish to become a speech pathologist in New Jersey, you can find the specifically relevant information at Speech Pathologist requirements in New Jersey.

Top Publications

  • Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent

    (2020)
    48 Citations
  • Spermidine and spermine exert protective effects within the lung.

    Marcin Wawrzyniak;David Groeger;Remo Frei;Ruth Ferstl

    (2021)
    34 Citations
  • Identification of the metabolites of ivermectin in humans.

    Phornpimon Tipthara;Kevin C. Kobylinski;Markus Godejohann;Borimas Hanboonkunupakarn

    (2021)
    31 Citations
  • Development of a machine learning algorithm for early detection of opioid use disorder.

    Zvi Segal;Kira Radinsky;Guy Elad;Gal Marom

    (2020)
    27 Citations
  • Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study

    (2022)
    21 Citations
  • Evaluation of claims-based computable phenotypes to identify heart failure patients with preserved ejection fraction.

    Sarah S. Cohen;Véronique L. Roger;Susan A. Weston;Ruoxiang Jiang

    (2020)
    19 Citations
  • Drp1-dependent peptide reverse mitochondrial fragmentation, a homeostatic response in Friedreich ataxia.

    Joseph Johnson;Elizabeth Mercado-Ayón;Elisia Clark;David Lynch;David Lynch

    (2021)
    18 Citations
  • Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers.

    Mohammad Al-Mahdi Al-Karagholi;Jakob Møller Hansen;Dalia Abou-Kassem;Anna Koldbro Hansted

    (2021)
    17 Citations
  • A practical treatment for COVID‐19 and the next pandemic

    (2022)
    17 Citations

Related Online Degrees & Career Pathways

For students interested in healthcare but not pursuing traditional medical school, there are multiple online degree options that offer flexibility and career advancement. Programs like direct entry MSN programs for non nurses online provide an accelerated path to becoming a nurse practitioner without prior nursing experience.

Nursing professionals looking to advance their credentials may consider RN to BSN programs. Popular comparisons such as capella vs wgu rn to bsn highlight key differences in curriculum, cost, and program flexibility to help students choose the best fit.

For those aiming to further their expertise, affordable online pathway options like bsn to msn bridge programs offer a cost-effective route to advanced nursing roles and leadership positions.

Additionally, many RN to BSN programs now offer options with no clinicals requirements, appealing to working professionals who need maximum flexibility. Exploring rn to bsn no clinicals programs can help students continue their education without compromising work or personal commitments.

Best Scientists Contributing to This Journal

Recently Published Articles